Department of Internal Medicine

Organization profile

Organisation profile

We are part of university—National Cheng Kung University, therefore, all of our staffs contribute significant amount of time to research and teaching, in addition to clinical service. We accept interns and visiting clerks from the other schools, including foreign students. Our colleagues have established close connections with national and international academic societies. We all expect our department develop an ideal environment for students to learn medicine and is the best place for patients to treat their diseases. ◎ Our Department has 11 divisions, including all the adults’ diseases; the divisions are Cardiology, Chest Medicine, Gastroenterology, Nephrology, Hemato-oncology, Rheumatology and Immunology, Endocrinology and Metabolism, Infection, Geriatrics, Critical care medicine and General medicine. We have 79 staffs (full-time attending physicians), 61 in training residents (R1 to R5), and 47 part-time attending physicians. Besides the residents, we have 19 interns (3 months, 4 shifts per year), 12 junior (6 weeks, 6 shifts per year) and 12 senior clerks (6 weeks, 6 shifts per year) participate our medical teams. They are medical students equal to PGY 1, the third and forth year’s students in the U. S. system.

Fingerprint The fingerprint is based on mining the text of the scientific documents related to the associated persons. Based on that an index of weighted terms is created, which defines the key subjects of research unit

Taiwan Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Helicobacter pylori Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Bacteremia Medicine & Life Sciences
Hepatocellular Carcinoma Medicine & Life Sciences
Klebsiella pneumoniae Medicine & Life Sciences
Chronic Hepatitis B Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1995 2018

Research Output 1987 2019

1-Arylsulfonyl indoline-benzamides as a new antitubulin agents, with inhibition of histone deacetylase

Lai, M. J., Ojha, R., Lin, M. H., Liu, Y. M., Lee, H. Y., Lin, T. E., Hsu, K. C., Chang, C. Y., Chen, M. C., Nepali, K., Chang, J-Y. & Liou, J. P., 2019 Jan 15, In : European Journal of Medicinal Chemistry. 162, p. 612-630 19 p.

Research output: Contribution to journalArticle

Benzamides
Histone Deacetylases
Tubulin
Heterografts
Inhibitory Concentration 50
1 Citations

2018 consensus of the Taiwan Society of Cardiology and the Diabetes Association of Republic of China (Taiwan) on the pharmacological management of patients with type 2 diabetes and cardiovascular diseases

Chiang, C. E., Lin, S. Y., Lin, T. H., Wang, T. D., Yeh, H. I., Chen, J. F., Tsai, C. T., Hung, Y. J., Li, Y-H., Liu, P-Y., Chang, K. C., Wang, K. L., Chao, T-H., Shyu, K. G., Yang, W. S., Ueng, K. C., Chu, P. H., Yin, W. H., Wu, Y. W., Cheng, H. M. & 7 othersShin, S. J., Huang, C. N., Chuang, L. M., Lin, S. J., Yeh, S. J., Sheu, W. H. H. & Lin, J. L., 2018 Mar 1, In : Journal of the Chinese Medical Association. 81, 3, p. 189-222 34 p.

Research output: Contribution to journalArticle

Cardiology
Taiwan
Type 2 Diabetes Mellitus
Cardiovascular Diseases
Pharmacology

2018 expert consensus on the management of adverse effects of antiplatelet therapy for acute coronary syndrome in Taiwan

Li, Y-H., Fang, C. Y., Hsieh, I. C., Huang, W. C., Lin, T. H., Sung, S. H., Chiu, C. Z., Wu, C. J., Shyu, K. G., Chang, P. Y., Fang, C. C., Lu, T. M., Chen, C. P., Tai, W. C., Sheu, C. C., Wei, K. C., Huang, Y. H., Wu, H. M. & Hwang, J. J., 2018 May 1, In : Acta Cardiologica Sinica. 34, 3, p. 201-210 10 p.

Research output: Contribution to journalReview article

Acute Coronary Syndrome
Taiwan
Platelet Aggregation Inhibitors
Ecchymosis
Hemorrhage